US Dollar Holds Near SixWeek High as Iran Tensions Boost SafeHaven Demand Nvidias Blockbuster Quarter Reveals 200 Billion Opportunity and Edge Computing Shift as China Market Conceded Aluminum Price Surge Amid Iran Conflict Pressures Major US Companies Prediction Market Signals Potential US Government Stakes in IonQ Micron and Anduril Nvidia H100 GPU Prices Rise 20 YTD Nebius Group Poised to Benefit from Tight AI Cloud Supply AIPowered Job Applications Spark Homogenization and Recruiter Doom Loop Industry Experts Warn Crane Company CR Q1 2026 Earnings EPS Beat Drives Modest Stock Gains Amid Mixed Operating Trends Old Republic International ORI Q1 2026 Earnings EPS Misses Estimates by 15 Stock Declines Natuzzi SpA NTZ Q4 2011 Earnings EPS Falls Short as Restructuring Weighs on Results Kyivstar Group Ltd KYIV Q1 2026 Earnings EPS Surprises to the Upside as Market Stays Cautious DSX Q4 2025 Earnings WiderThanExpected Loss Highlights Persistent Headwinds in Dry Bulk Market REAL Q1 2026 Earnings Narrowing Losses as Consignment Volumes Improve Fidelis Insurance Holdings FIHL Slips Slightly Testing Support Levels Rogers Corporation ROG Posts Modest Gains as Price Holds Above Support Advent Convertible and Income Fund AVK Edges Lower Amid Sector Rotation DIAX Shares Edge Lower as IncomeFocused Fund Navigates Market Uncertainty Pulmatrix Inc PULM Holds Steady at 134 as Key Support and Resistance Levels Tighten Bunge Limited BG Rises 13 Key Levels and Sector Strength Eaton Vance TaxManaged Diversified Equity Income Fund ETY Edges Higher Amid Cautious Trading Ally Financial ALLY Holds Steady Near 43 as Volume Signals Cautious Optimism Morgan Stanley MS Edges Higher Testing Key Resistance Levels Amidst Financial Sector Strength Here Group HERE Declines 255 Testing Key Support Zone TriNet Group TNET Gains 227 as Stock Approaches Key Resistance Level Quantinuum Sets IPO Terms Quantum Computing Company Targets Nearly 13 Billion Valuation Rapid7 Q1 2026 Earnings EPS Surpasses Estimates by 1765 Polaryx Therapeutics PLYX Slips 863 as Biotech Volatility Resurfaces Key Support Levels in Focus